- Home
- USA vs RXRX Comparison
USA vs RXRX Comparison
Compare USA & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USA | RXRX |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | USA | RXRX |
|---|---|---|
| Price | $5.65 | $3.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 1.4M | ★ 20.5M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $5.40 | $2.77 |
| 52 Week High | $6.96 | $7.18 |
Technical Indicators
Market Signals| Indicator | USA | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 48.79 |
| Support Level | $5.40 | $2.88 |
| Resistance Level | $5.89 | $4.01 |
| Average True Range (ATR) | 0.08 | 0.26 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 10.00 | 24.31 |
Price Performance
Historical ComparisonAbout USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.